SeaStar Medical Holding Corp (ICU) Form 8-K — Jun 17, 2026
SeaStar Medical Holding Corporation held its annual meeting of stockholders on June 17, 2026, where voters elected John Neuman to serve as a Class I director until the 2029 annual meeting. Stockholders approved an amendment and restatement of the Company’s 2022 Omnibus Incentive Plan, increasing the number of authorized shares of common stock reserved for issuance from 207,046 shares to 896,546 shares. This adjustment reflects the impact of a 1-for-10 reverse stock split that occurred on January 5, 2026.
Key figures
- Shares Authorized New
- 896546
- Shares Authorized Prior
- 207046
- Max Iso Value Per Employee
- 100000
- Max Non Employee Director Award
- 500000
- Reverse split ratio
- 1-for-10
- Votes for plan amendment
- 551233
- Votes for auditor ratification
- 2151096
- Votes for director john neuman
- 757141
Price after filing
Close on the filing date to close N calendar days later (from $3.06). Historical, not a forecast.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.